Abstract
There are evidences that besides geographic tendency, interactions between genetic and environmental factors play an essential role in the pathogenesis of Behçet’s disease (BD). In this study, we have evaluated the associations between rs4810485 and rs1883832 single nucleotide polymorphism (SNP)s of CD40 gene with the susceptibility and clinical findings of BD. Two hundred and eighty-five patients with BD and 225 age-matched healthy controls were enrolled in this study. The clinical findings of patients were noted. The distributions of genotypes, alleles, combined genotypes and haplotypes of these two SNPs in BD patients were compared with those in healthy controls. In further evaluation, we evaluated the patients with and without any of clinical findings with regarding to distribution of genotypes and alleles of these two SNPs. There was no significant difference concerning frequencies of genotypes, alleles, combined genotypes and haplotypes of rs4810485 and rs1883832 between patients and controls (p > 0.05 for all). Frequency of GT genotype of CD40 rs4810485 polymorphism was found to be significantly higher in patients with skin lesions (p < 0.05, OR 1.65, 95 % CI 1.02–2.64). Also, we have found significantly higher frequencies of CC genotype and C allele of CD40 rs1883832 polymorphism in patients with genital ulcers (p < 0.05 for both, OR 2.30, 95 % CI 1.07–4.94 and OR 1.78, 95 % CI 1.06–2.97, respectively). However, these significances were disappeared after Bonferroni correction. We suggest that differences in the expression levels of CD40 because of different genotypes of these two SNPs may take part in the development of skin lesions or genital ulcers in patients with BD.
Similar content being viewed by others
References
Dalvi SR, Yıldırım R, Yazıcı Y (2010) Behcet’s syndrome. Drugs 72:2223–2241
Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, Tunç R, Urgancioğlu M, Dişçi R (2003) Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol 42:803–806
Idil A, Gürler A, Boyvat A, Caliskan D, Ozdemir O, Isik A, Tunçbilek A, Koçyigit P, Calikoglu E (2002) The prevalence of Behçet’s disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol 9:325–331
Cakir N, Dervis E, Benian O, Pamuk ON, Sonmezates N, Rahimoglu R, Tuna S, Cetin T, Sarikaya Y (2004) Prevalence of Behçet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol 22:S53–S55
Gül A (2005) Behçet’s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83
Alpsoy E, Donmez L, Onder M, Gunasti S, Usta A, Karincaoglu Y, Kandi B, Buyukkara S, Keseroglu O, Uzun S, Tursen U, Seyhan M, Akman A (2007) Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study. Br J Dermatol 157:901–906
Cho S, Cho SB, Choi MJ, Zheng Z, Bang D (2013) Behçet’s disease in concurrence with psoriasis. J Eur Acad Dermatol Venereol 27:e113–e118
Araki Y, Akita T, Usui A, Ichihashi R, Ito M, Ueda Y (2007) Aortic arch aneurysm of Takayasu arteritis associated with entero-Behçet disease. Ann Thorac Cardiovasc Surg 13:216–219
Iwadate H, Ohira H, Saito H, Takahashi A, Rai T, Takiguchi J, Sasajima T, Kobayashi H, Watanabe H, Sato Y (2006) A case of primary biliary cirrhosis complicated by Behçet’s disease and palmoplantar pustulosis. World J Gastroenterol 12:2136–2138
Cho SB, Lee JH, Ahn KJ, Bae BG, Kim T, Park YB, Lee SK, Lee KH, Bang D (2012) Anti-cyclic citrullinated peptide antibodies and joint involvement in Behçet’s disease. Yonsei Med J 53:759–764
Kang EH, Kim JY, Takeuchi F, Kim JW, Shin K, Lee EY, Lee YJ, Lee EB, Park MH, Song YW (2011) Associations between the HLA-A polymorphism and the clinical manifestations. Arthritis Res Ther 13:R49
Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M (1982) Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol 100:1455–1458
Akman A, Sallakcı N, Coşkun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O (2006) TNF-alfa gene 1031 T/C polymorphism in Turkish patients with Behçet’s disease. Br J Dermatol 155:350–356
Atagündüz P, Ergun T, Direskeneli H (2003) MEFV mutations are increased in Behçet’s disease and are associated with vascular involvement. Clin Exp Rheumatol 21:35–37
Chen F, Hou S, Jiang Z, Chen Y, Kijlstra A, Rosenbaum JT, Yang P (2012) CD40 gene polymorphisms confer risk of Behçet’s disease but not of Vogt-Koyanagi-Harada syndrome in Han Chinese population. Rheumatology 51:47–51
Lee EB, Kim JY, Zhao J, Park MH, Song YW (2007) Haplotype association of IL-8 gene with Behcet’s disease. Tissue Antigens 69:128–132
Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, Cho YH, Bang D, O’Shea J, Wallace GR, Gadina M, Kastner DL, Gül A (2010) Genome-wide association study identifies variants in the MHC class I, IL-10 and IL23R-IL12RB2 regions associated with Behcet’s disease. Nat Genet 42:698–702
Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Sacli FS, Erer B, Inoko H, Emrence Z, Cakar A, Abaci N, Ustek D, Satorius C, Ueda A, Takeno M, Kim Y, Wood GM, Ombrello MJ, Meguro A, Gül A, Remmers EF, Kastner DL (2013) Genome-wide association analysis identifies new susceptibility loci for Behçet’s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 45:202–207
Hou S, Xiao X, Li F, Jiang Z, Kijlstra A, Yang P (2012) Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Behçet’s disease susceptibility. Hum Genet 131:1841–1850
Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, Li F, Zhou Q, Ohno S, Chen R, Kijlstra A, Rosenbaum JT, Yang P (2012) Identification of a susceptibility locus in STAT4 for Behçet’s disease in Han Chinese in a genome-wide association study. Arthritis Rheum 64:4104–4113
Sawalha AH, Hughes T, Nadig A, Yılmaz V, Aksu K, Keser G, Cefle A, Yazıcı A, Ergen A, Alarcón-Riquelme ME, Salvarani C, Casali B, Direskeneli H, Saruhan-Direskeneli G (2011) A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet’s disease. Arthritis Rheum 63:3607–3612
Hou S, Shu Q, Jiang Z, Chen Y, Li F, Chen F, Kijlstra A, Yang P (2012) Replication study confirms the association between UBAC2 and Behçet’s disease in two independent Chinese sets of patients and controls. Arthritis Res Ther 14:R70
Cvetanovich GL, Hafler DA (2010) Human regulatory T cells in autoimmune diseases. Curr Opin Immunol 22:753–760
Kuhn A, Beissert S, Krammer PH (2009) CD4(+) CD25(+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res 301:71–81
Sugita S, Yamada Y, Kaneko S, Horie S, Mochizuki M (2011) Induction of regulatory T cells by infliximab in Behcet’s disease. Invest Ophthalmol Vis Sci 52:476–484
Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ (1996) Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14:591–617
Xu Y, Song G (2004) The role of CD40-CD154 interaction in cell immunoregulation. J Biomed Sci 11:426–438
Wang H, Yang PZ, Peng XY, Zhao M, Zhou HY, Huang XK (2009) An increased expression of CD40/CD40L costimulatory molecules in erythema nodosum of patients with Behcet’s disease. Int J Ophthalmol 2:12–15
Joo YB, Park BL, Shin HD, Park SY, Kim I, Bae SC (2013) Association of genetic polymorphisms in CD40 with susceptibility to SLE in Korean population. Rheumatology 52:630–632
García-Bermúdez M, González-Juanatey C, López-Mejías R, Teruel M, Corrales A, Miranda-Filloy JA, Castañeda S, Balsa A, Fernández-Gutierrez B, González-Álvaro I, Gómez-Vaquero C, Blanco R, Llorca J, Martín J, González-Gay MA (2012) Study of Association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish Rheumatoid Arthritis patients. PLoS One 7:e49214
Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, Gianniny L, Korman BD, Padyukov L, Kurreeman FA, Chang M, Catanese JJ, Ding B, Wong S, van der Helm-van Mil AH, Neale BM, Coblyn J, Cui J, Tak PP, Wolbink GJ, Crusius JB, van der Horst-Bruinsma IE, Criswell LA, Amos CI, Seldin MF, Kastner DL, Ardlie KG, Alfredsson L, Costenbader KH, Altshuler D, Huizinga TW, Shadick NA, Weinblatt ME, de Vries N, Worthington J, Seielstad M, Toes RE, Karlson EW, Begovich AB, Klareskog L, Gregersen PK, Daly MJ, Plenge RM (2008) Common variants at the CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 40:1216–1223
Jacobson E, Concepcion E, Oashi T, Tomer Y (2005) A Graves’ Disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146:2684–2691
Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Marí-Alfonso B, Gómez-Vaquero C, Miranda-Filloy JA, Narvaez J, Ortego-Centeno N, Blanco R, Fernández-Gutiérrez B, Martín J, González-Gay MA (2010) Influence of CD40 rs1883832 polymorphism in susceptibility to and clinical manifestations of biopsy-proven giant cell arteritis. J Rheumatol 37:2076–2080
Blanco-Kelly F, Matesanz F, Alcina A, Teruel M, Díaz-Gallo LM, Gómez-García M, López-Nevot MA, Rodrigo L, Nieto A, Cardeña C, Alcain G, Díaz-Rubio M, de la Concha EG, Fernandez O, Arroyo R, Martín J, Urcelay E (2010) CD40 novel association with Crohn’s disease and replication in multiple sclerosis susceptibility. PLoS One 5:e11520
Jacobson EM, Huber AK, Akeno N, Sivak M, Li CW, Concepcion E, Ho K, Tomer Y (2007) A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-spesific expression. Genes Immun 8:205–214
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD) (2014) The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347
Zervou MI, Goulielmos GN, Castro-Giner F, Boumpas DT, Tosca AD, Krueger-Krasagakis S (2011) A CD40 and an NCOA5 gene polymorphism confer susceptibility to psoriasis in a Southern European population: a case-control study. Hum Immunol 72:761–765
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
İnal, E.E., Rüstemoğlu, A., İnanır, A. et al. Associations of rs4810485 and rs1883832 polymorphisms of CD40 gene with susceptibility and clinical findings of Behçet’s disease. Rheumatol Int 35, 837–843 (2015). https://doi.org/10.1007/s00296-014-3171-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-014-3171-3